However, vvDD-IL-2-FG and vvDD-IL-2-RG significantly extended survival, with vvDD-IL-2-RG having the greatest impact on survival, substantially decreasing tumor volume in murine colon, lung, and ovarian cancer models. This evidence concerns the gene IL2 and ovarian carcinoma.